{"id":406968,"date":"2020-12-31T13:19:00","date_gmt":"2020-12-31T18:19:00","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=406968"},"modified":"2020-12-31T13:19:00","modified_gmt":"2020-12-31T18:19:00","slug":"betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/","title":{"rendered":"BetterInvesting\u2122 Magazine Chooses CVS Health Corp. As “Growth” Stock and Charles Schwab Corp. As “Undervalued” For March 2021 Issue"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n MADISON HEIGHTS, Mich.<\/span>, Dec. 31, 2020<\/span> \/PRNewswire\/ — The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced CVS Health Corp.<\/a>\u00a0(NYSE: CVS) as its “Stock to Study” and Charles Schwab Corp.<\/a>\u00a0(NYSE: SCHW) its “Undervalued Stock” in the March 2021<\/span> issue for investors’ informational and educational use.<\/p>\n

“Interest and participation in the stock market among individual investors, accelerated by the pandemic, has reached unprecedented\u00a0levels,” said Doron P. Levin<\/span>, editor of BetterInvesting Magazine. “Never before have skill, knowledge and the time-tested principles for intelligently selecting equities yielded so much value for those who possess them.”<\/p>\n

Check BetterInvesting’s March 2021<\/span> issue for more details about these stock selections. Go to the trial version of BetterInvesting’s online tools<\/a>\u00a0to study the investment potential of CVS and Charles Schwab<\/span> by viewing their fundamental data and applying judgments.<\/p>\n

Committee members are Robert M. Bilkie, Jr.<\/span>, CFA; Daniel J. Boyle<\/span>, CFA; Marisa Bradbury<\/span>, CFA; Philip Keating<\/span>, CFA; Philip S. Dano<\/span>, CFA; and Walter J. Kirchberger<\/span>, CFA.<\/p>\n

As stated, the BetterInvesting committee’s Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors and are not intended as investment recommendations. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases. <\/p>\n

\n About BetterInvesting:<\/b>\n <\/p>\n

\n BetterInvesting, a national\u00a0<\/i>
\n 501(c)(3) nonprofit, investment education organization,\u00a0has been empowering everyday Americans since 1951. Also known as\u00a0the National Association of Investors Corporation (NAIC),\u00a0we have helped more than 5 million people from all walks of life learn how to improve their financial future.\u00a0BetterInvesting is\u00a0dedicated to providing unbiased, in-depth investing education and powerful online stock analysis tools in order to create successful lifelong investors.\u00a0BetterInvesting staff along with a dedicated community of volunteers across America\u00a0teach\u00a0the organization’s principles and time-tested methodology to both individuals and investment clubs.\u00a0For more information about BetterInvesting, please visit\u00a0www.betterinvesting.org<\/a><\/i>.<\/p>\n

Follow us on LinkedIn<\/a>\u00a0and Facebook<\/a>.<\/p>\n

CONTACT: 877-275-6242<\/p>\n

\n \"Cision\" View original content:http:\/\/www.prnewswire.com\/news-releases\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue-301199747.html<\/a><\/p>\n

SOURCE NAIC-BetterInvesting<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire MADISON HEIGHTS, Mich., Dec. 31, 2020 \/PRNewswire\/ — The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced CVS Health Corp.\u00a0(NYSE: CVS) as its “Stock to Study” and Charles Schwab Corp.\u00a0(NYSE: SCHW) its “Undervalued Stock” in the March 2021 issue for investors’ informational and educational use. “Interest and participation in the stock market among individual investors, accelerated by the pandemic, has reached unprecedented\u00a0levels,” said Doron P. Levin, editor of BetterInvesting Magazine. “Never before have skill, knowledge and the time-tested principles for intelligently selecting equities yielded so much value for those who possess them.” Check BetterInvesting’s March 2021 issue for more details about these stock selections. Go to the trial version of BetterInvesting’s online tools\u00a0to study the … <\/p>\n

Continue reading “BetterInvesting\u2122 Magazine Chooses CVS Health Corp. As “Growth” Stock and Charles Schwab Corp. As “Undervalued” For March 2021 Issue”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-406968","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBetterInvesting\u2122 Magazine Chooses CVS Health Corp. As "Growth" Stock and Charles Schwab Corp. As "Undervalued" For March 2021 Issue - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BetterInvesting\u2122 Magazine Chooses CVS Health Corp. As "Growth" Stock and Charles Schwab Corp. As "Undervalued" For March 2021 Issue - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire MADISON HEIGHTS, Mich., Dec. 31, 2020 \/PRNewswire\/ — The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced CVS Health Corp.\u00a0(NYSE: CVS) as its “Stock to Study” and Charles Schwab Corp.\u00a0(NYSE: SCHW) its “Undervalued Stock” in the March 2021 issue for investors’ informational and educational use. “Interest and participation in the stock market among individual investors, accelerated by the pandemic, has reached unprecedented\u00a0levels,” said Doron P. Levin, editor of BetterInvesting Magazine. “Never before have skill, knowledge and the time-tested principles for intelligently selecting equities yielded so much value for those who possess them.” Check BetterInvesting’s March 2021 issue for more details about these stock selections. Go to the trial version of BetterInvesting’s online tools\u00a0to study the … Continue reading "BetterInvesting\u2122 Magazine Chooses CVS Health Corp. As “Growth” Stock and Charles Schwab Corp. As “Undervalued” For March 2021 Issue"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-31T18:19:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC35703&sd=2020-12-31\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BetterInvesting\u2122 Magazine Chooses CVS Health Corp. As “Growth” Stock and Charles Schwab Corp. As “Undervalued” For March 2021 Issue\",\"datePublished\":\"2020-12-31T18:19:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\\\/\"},\"wordCount\":350,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=DC35703&sd=2020-12-31\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\\\/\",\"name\":\"BetterInvesting\u2122 Magazine Chooses CVS Health Corp. As \\\"Growth\\\" Stock and Charles Schwab Corp. As \\\"Undervalued\\\" For March 2021 Issue - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=DC35703&sd=2020-12-31\",\"datePublished\":\"2020-12-31T18:19:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=DC35703&sd=2020-12-31\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=DC35703&sd=2020-12-31\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BetterInvesting\u2122 Magazine Chooses CVS Health Corp. As “Growth” Stock and Charles Schwab Corp. As “Undervalued” For March 2021 Issue\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BetterInvesting\u2122 Magazine Chooses CVS Health Corp. As \"Growth\" Stock and Charles Schwab Corp. As \"Undervalued\" For March 2021 Issue - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/","og_locale":"en_US","og_type":"article","og_title":"BetterInvesting\u2122 Magazine Chooses CVS Health Corp. As \"Growth\" Stock and Charles Schwab Corp. As \"Undervalued\" For March 2021 Issue - Market Newsdesk","og_description":"PR Newswire MADISON HEIGHTS, Mich., Dec. 31, 2020 \/PRNewswire\/ — The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced CVS Health Corp.\u00a0(NYSE: CVS) as its “Stock to Study” and Charles Schwab Corp.\u00a0(NYSE: SCHW) its “Undervalued Stock” in the March 2021 issue for investors’ informational and educational use. “Interest and participation in the stock market among individual investors, accelerated by the pandemic, has reached unprecedented\u00a0levels,” said Doron P. Levin, editor of BetterInvesting Magazine. “Never before have skill, knowledge and the time-tested principles for intelligently selecting equities yielded so much value for those who possess them.” Check BetterInvesting’s March 2021 issue for more details about these stock selections. Go to the trial version of BetterInvesting’s online tools\u00a0to study the … Continue reading \"BetterInvesting\u2122 Magazine Chooses CVS Health Corp. As “Growth” Stock and Charles Schwab Corp. As “Undervalued” For March 2021 Issue\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-31T18:19:00+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC35703&sd=2020-12-31","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BetterInvesting\u2122 Magazine Chooses CVS Health Corp. As “Growth” Stock and Charles Schwab Corp. As “Undervalued” For March 2021 Issue","datePublished":"2020-12-31T18:19:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/"},"wordCount":350,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC35703&sd=2020-12-31","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/","name":"BetterInvesting\u2122 Magazine Chooses CVS Health Corp. As \"Growth\" Stock and Charles Schwab Corp. As \"Undervalued\" For March 2021 Issue - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC35703&sd=2020-12-31","datePublished":"2020-12-31T18:19:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC35703&sd=2020-12-31","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC35703&sd=2020-12-31"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/betterinvesting-magazine-chooses-cvs-health-corp-as-growth-stock-and-charles-schwab-corp-as-undervalued-for-march-2021-issue\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BetterInvesting\u2122 Magazine Chooses CVS Health Corp. As “Growth” Stock and Charles Schwab Corp. As “Undervalued” For March 2021 Issue"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/406968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=406968"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/406968\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=406968"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=406968"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=406968"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}